CH EPL (R5)
1.0.0-ballot - ballot
This page is part of the CH EPL (R5) (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: RegulatedAuthorization FOPH-20416
CH - EPL Reimbursement SL
- FOPHDossierNumber: FOPH Dossier Number/20416
- status: Reimbursed
- statusDate: 2023-01-01
- expiryDate: 2025-03-31
- listingStatus: Listed
- listingPeriod: 2023-01-01 --> 2024-12-31
- firstListingDate: 2017-09-01
- costShare: 10
- gamme: Parenteral Depot
CH - EPL Product Price
- value: CHF4,407.68 (CHF)
- type: Ex-factory price
- changeType: Normal price mutation
- changeDate: 2023-01-01
CH - EPL Product Price
- value: CHF4,768.50 (CHF)
- type: Retail price
- changeType: VAT-change
- changeDate: 2024-01-01
type: Reimbursement SL
| Extension | Reference |
| ClinicalUseDefinition: type = indication |
holder: Organization MSD Merck Sharp & Dohme AG
Generated Narrative: Organization #holder-MSD-Merck-Sharp-Dohme-AG
Profile: CH EPL Organization
identifier: LOC Identifier/100080484, GLN Identifier/7601001001138
name: MSD Merck Sharp & Dohme AG